Wed, May 17, 2023
Tue, May 16, 2023
Mon, May 15, 2023
Fri, May 12, 2023

Leland Gershell Reiterated (URGN) at Buy and Held Target at $22 on, May 15th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-22-on-may-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Leland Gershell of Oppenheimer, Reiterated "UroGen Pharma Ltd." (URGN) at Buy and Held Target at $22 on, May 15th, 2023.

Leland has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, all agrees with Leland's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $10 on, Wednesday, February 8th, 2023